Ambu A/S (AMBU-B.CO)
- Previous Close
113.30 - Open
112.90 - Bid 111.90 x --
- Ask 112.05 x --
- Day's Range
111.95 - 113.05 - 52 Week Range
65.62 - 126.20 - Volume
46,421 - Avg. Volume
528,970 - Market Cap (intraday)
29.813B - Beta (5Y Monthly) 0.87
- PE Ratio (TTM)
124.39 - EPS (TTM)
0.90 - Earnings Date May 14, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 15, 2021
- 1y Target Est
121.80
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.
www.ambu.comRecent News: AMBU-B.CO
Performance Overview: AMBU-B.CO
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AMBU-B.CO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AMBU-B.CO
Valuation Measures
Market Cap
30.17B
Enterprise Value
30.52B
Trailing P/E
125.89
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.14
Price/Book (mrq)
5.57
Enterprise Value/Revenue
6.23
Enterprise Value/EBITDA
44.30
Financial Highlights
Profitability and Income Statement
Profit Margin
4.86%
Return on Assets (ttm)
3.25%
Return on Equity (ttm)
4.99%
Revenue (ttm)
4.9B
Net Income Avi to Common (ttm)
238M
Diluted EPS (ttm)
0.90
Balance Sheet and Cash Flow
Total Cash (mrq)
277M
Total Debt/Equity (mrq)
11.59%
Levered Free Cash Flow (ttm)
480.5M
Research Analysis: AMBU-B.CO
Company Insights: AMBU-B.CO
AMBU-B.CO does not have Company Insights